ANDERMAN JONATHAN (Sr VP, Gen Counsel & Corp Sec) received a stock award from COMPASS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/29/2026ACC: 0001171843-26-002840
Officer· Sr VP, Gen Counsel & Corp Sec
Since Aug 2024
+25K
Net shares
Net buyer
$47.3K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$1.89
Trade value
$47.25K
% of position
14.6%
4/29/2026
171K→196K
Total
Net shares
+25K
Net value
$47.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/29/2026 | A · Award | +25K | $1.89 | $47.25K | 14.6% | 171K | 196K |
| Total | +25K | $47.25K | ||||||
Derivative Transactions0
No derivative transactions reported